Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP432031.RAwEOp9LbFgUHAq6HqoCYX3KlFM8AOobgMfIiC1wGwnw4130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP432031.RAwEOp9LbFgUHAq6HqoCYX3KlFM8AOobgMfIiC1wGwnw4130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP432031.RAwEOp9LbFgUHAq6HqoCYX3KlFM8AOobgMfIiC1wGwnw4130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP432031.RAwEOp9LbFgUHAq6HqoCYX3KlFM8AOobgMfIiC1wGwnw4130_provenance.
- NP432031.RAwEOp9LbFgUHAq6HqoCYX3KlFM8AOobgMfIiC1wGwnw4130_assertion description "[RUNX3 methylation was also detected in hepatocellular carcinomas (73%, n=48), larynx cancers (62%, n=37), lung cancers (46%, n=24), breast cancers (25%, n=25), prostate cancers (23%, n=44), endometrial cancers (12.5%, n=24), colon cancers (4.9%, n=61) and uterine cervical cancers (2.5%, n=40), showing that RUNX3 methylation is not restricted to gastric cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP432031.RAwEOp9LbFgUHAq6HqoCYX3KlFM8AOobgMfIiC1wGwnw4130_provenance.
- NP432031.RAwEOp9LbFgUHAq6HqoCYX3KlFM8AOobgMfIiC1wGwnw4130_assertion evidence source_evidence_literature NP432031.RAwEOp9LbFgUHAq6HqoCYX3KlFM8AOobgMfIiC1wGwnw4130_provenance.
- NP432031.RAwEOp9LbFgUHAq6HqoCYX3KlFM8AOobgMfIiC1wGwnw4130_assertion SIO_000772 14968123 NP432031.RAwEOp9LbFgUHAq6HqoCYX3KlFM8AOobgMfIiC1wGwnw4130_provenance.
- NP432031.RAwEOp9LbFgUHAq6HqoCYX3KlFM8AOobgMfIiC1wGwnw4130_assertion wasDerivedFrom befree-2016 NP432031.RAwEOp9LbFgUHAq6HqoCYX3KlFM8AOobgMfIiC1wGwnw4130_provenance.
- NP432031.RAwEOp9LbFgUHAq6HqoCYX3KlFM8AOobgMfIiC1wGwnw4130_assertion wasGeneratedBy ECO_0000203 NP432031.RAwEOp9LbFgUHAq6HqoCYX3KlFM8AOobgMfIiC1wGwnw4130_provenance.
- befree-2016 importedOn "2016-02-19" NP432031.RAwEOp9LbFgUHAq6HqoCYX3KlFM8AOobgMfIiC1wGwnw4130_provenance.